Amicus Therapeutics Inc. buy Morgan Stanley
Start price
19.12.23
/
50%
€12.00
Target price
19.12.24
€18.24
Performance (%)
-22.50%
End price
20.12.24
€9.30
Summary
This prediction ended on 20.12.24 with a price of €9.30. The price of Amicus Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.50%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -0.826% | -0.826% | 40.351% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Morgan_Stanley for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $15.00.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.45
11.10.24
11.10.24
€16.44
11.10.25
11.10.25
-24.34%
12.10.25
12.10.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.60
10.05.24
10.05.24
€17.64
10.05.25
10.05.25
-37.79%
11.05.25
11.05.25